Equillium (EQ) Interest Expenses (2018 - 2023)
Equillium (EQ) reported Interest Expenses of $259000.0 for Q2 2023, little changed year-over-year from $259000.0 in Q2 2022, and up 11.64% quarter-over-quarter from $232000.0 in Q1 2023.
Equillium (EQ) Interest Expenses (2018 - 2023) Analysis & Trends
Equillium (EQ) has 6 years of Interest Expenses data on file, last reported at $259000.0 in Q2 2023.
- Interest Expenses for Q2 2023 came in at $259000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2024 was $259000.0 (down 74.83% YoY), and the FY2023 annual result was $491000.0, down 53.37% from the prior year.
- Interest Expenses rose to $259000.0 in Q2 2023 per EQ's latest filing, from $232000.0 in the prior quarter.
- Over five years, Interest Expenses peaked at $277000.0 in Q4 2019 and troughed at $2000.0 in Q3 2019.
- A 5-year average of $249625.0 and a median of $268500.0 in 2021 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2019 and 2020: Interest Expenses sank 99.84% in 2019, then surged 13700.0% in 2020.
- A 5-year view of Interest Expenses shows it stood at $277000.0 in 2019, then retreated by 0.36% to $276000.0 in 2020, then dropped by 3.62% to $266000.0 in 2021, then rose by 1.88% to $271000.0 in 2022, then retreated by 4.43% to $259000.0 in 2023.
- Business Quant data shows EQ's Interest Expenses at $259000.0 in Q2 2023, $232000.0 in Q1 2023, and $271000.0 in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Equillium | 293.17 Mn | 232.78 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 259,000.00 |
| Jun 30, 2023 | 259,000.00 |
| Mar 31, 2023 | 232,000.00 |
| Mar 31, 2023 | 232,000.00 |
| Dec 31, 2022 | 271,000.00 |
| Dec 31, 2022 | 271,000.00 |
| Sep 30, 2022 | 267,000.00 |
| Sep 30, 2022 | 267,000.00 |
| Jun 30, 2022 | 259,000.00 |
| Jun 30, 2022 | 259,000.00 |
| Mar 31, 2022 | 255,000.00 |
| Mar 31, 2022 | 255,000.00 |
| Dec 31, 2021 | 266,000.00 |
| Dec 31, 2021 | 266,000.00 |
| Sep 30, 2021 | 266,000.00 |
| Sep 30, 2021 | 266,000.00 |
| Jun 30, 2021 | 270,000.00 |
| Jun 30, 2021 | 270,000.00 |
| Mar 31, 2021 | 271,000.00 |
| Mar 31, 2021 | 271,000.00 |